Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial
Wissenschaftlicher Artikel
Institutions
Bezirkskrankenhaus GünzburgPublished in
PLoS Medicine ; 15 (2018), 9. - Art.-Nr. e1002660. - ISSN 1549-1676
Link to publication
https://dx.doi.org/10.1371/journal.pmed.1002660Funding information
European Commission [279093]
UCLH NIHR Biomedical Research Centre, UK
Hauts-de-Freance Region, France
UCLH NIHR Biomedical Research Centre, UK
Hauts-de-Freance Region, France
EU Project
NILVAD / A European multicentre double-blind placebo-controlled phase III trial of nilvadIpine in mild to moderate Alzheimer’s disease / EC / FP7 / 279093